[Current aspects of melanoma].
D000951:Antigens, Neoplasm; D001402:B-Lymphocytes / Q000276:immunology; D004359:Drug Therapy, Combination; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007093:Imidazoles / Q000627:therapeutic use; D008545:Melanoma; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D011230:Precancerous Conditions; D011379:Prognosis; D013601:T-Lymphocytes / Q000276:immunology; D014165:Transfer Factor / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000951:Antigens, Neoplasm; D007093:Imidazoles; D009607:Nitrosourea Compounds; D014165:Transfer Factor; D014750:Vincristine; D006918:Hydroxyurea
Nouveaux aspects du mélanome